Three of the losses occurred in pregnancies in which JAK2 was the driver mutation (two first trimester losses and the stillbirth), and two losses occurred in pregnancies with triple‐negative MPN (one first trimester loss and the second trimester loss). Here, JAK2 is linked to myeloproliferative disorder.